New Zealand markets open in 4 hours 17 minutes

REMSleep Holdings, Inc. (RMSL)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0210+0.0029 (+16.02%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.0181
Open0.0189
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0181 - 0.0223
52-week range0.0030 - 0.0472
Volume45,601,374
Avg. volume15,450,818
Market cap20.292M
Beta (5Y monthly)-2.40
PE ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Condensation Testing Per ISO 18562-4:2017

    Tampa, FL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL): The company announces that testing for ISO 18562-4:2017 has been completed. We are actively compiling all necessary documentation to submit the analysis to the FDA to proceed with our current 510k application. Further updates will be forthcoming. We look forward to concluding our 510k application with the FDA very soon. Forward-looking statements. Some statements in this release may contain

  • GlobeNewswire

    REMSleep Announces Condensation Testing per ISO 18562-4 :2017

    Tampa, FL, Nov. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL): The company has engaged testing company to complete the condensation testing per ISO 18562-4:2017. Testing samples have been received by testing company and process is initiated. The company expects test results as early as 4 weeks. After considerable correspondence from FDA examiner the company expects this to be final testing required. Forward-looking statements. Some statements in this r

  • GlobeNewswire

    REMSleep 510K Submission

    Condensation testing per ISO 18562-4 :2017 Tampa, FL, Oct. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL): The company has been advised by the FDA after considerable correspondence that additional testing is required for its 510K submission. Remsleep is proceeding with the testing as soon as possible. Proceeds from Reg A will be used for additional product development, expected new patent application(s), aggressive marketing, product inventory after 510